This study describes sources of initial safety signals that that preceded US Food and Drug Administration (FDA) drug safety communications and examines their associations with drug characteristics and subsequent label changes.
No takes yet. Share an insight, caveat, or question.
Tau et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: